Driehaus Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Driehaus Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,235	Closed	-$309K	–	428
2024 Q4	$309K	Hold	11,235	–	–	﹤0.01%	373
2024 Q3	$323K	Hold	11,235	–	–	﹤0.01%	356
2024 Q2	$278K	Hold	11,235	–	–	﹤0.01%	345
2024 Q1	$362K	Hold	11,235	–	–	﹤0.01%	358
2023 Q4	$457K	Hold	11,235	–	–	0.01%	342
2023 Q3	$388K	Hold	11,235	–	–	0.01%	358
2023 Q2	$457K	Hold	11,235	–	–	0.01%	346
2023 Q1	$434K	Hold	11,235	–	–	0.01%	341
2022 Q4	$499K	Sell	11,235 -317,353	-97%	-$13.4M	0.01%	313
2022 Q3	$14M	Sell	328,588 -182,061	-36%	-$9.33M	0.21%	145
2022 Q2	$28.5M	Buy	510,649 +33,034	+7%	+$1.96M	0.46%	57
2022 Q1	$29.6M	Buy	+477,615	New	+$29.2M	0.36%	90
2017 Q4	–	Sell	-5,988	Closed	-$609K	–	563
2017 Q3	$609K	Sell	5,988 -4,815	-45%	-$421K	0.02%	368
2017 Q2	$827K	Sell	10,803 -125	-1%	-$10.5K	0.03%	366
2017 Q1	$942K	Buy	+10,928	New	+$787K	0.03%	368
2016 Q1	–	Sell	-26,890	Closed	-$1.69M	–	582
2015 Q4	$1.69M	Buy	+26,890	New	+$1.37M	0.06%	323

Other funds holding LKFT

Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Driehaus Capital Management's LKFT Position: Q1 2025 in Review

Driehaus Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2025, closing a stake of 11,235 shares — an estimated $309K sold.

Driehaus Capital Management first reported a position in LKFT in Q4 2015 and held it in 16 quarters. The position peaked at $29.6M in Q1 2022. 83 funds tracked by Wall St. Rank hold LKFT as of Q1 2025.

Driehaus Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2025 after selling out during the quarter.
Driehaus Capital Management sold 11,235 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2025, an estimated $309K.
Driehaus Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2015 and held it in 16 quarters.
Driehaus Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $29.6M in Q1 2022.
83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2025.

Based on Driehaus Capital Management's 13F filing for Q1 2025, filed 15 May 2025.